SHERRIE URENA: Open Payments
NPI 1245368992 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,265 in 323 payments from 15 companies in 2025. Trend: 2023 $3,859 · 2024 $5,060 · 2025 $11,265
Food & beverage: $5,711Speaker / faculty: $5,196Education: $280Travel & lodging: $77
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 116 | $7,612 |
| Otsuka America Pharmaceutical, Inc. | 43 | $634 |
| Alkermes, Inc. | 29 | $613 |
| Janssen Pharmaceuticals, Inc | 17 | $479 |
| E.R. Squibb & Sons, L.L.C. | 10 | $390 |
| Vanda Pharmaceuticals Inc. | 23 | $380 |
| ABBVIE INC. | 37 | $340 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $228 |
| Lundbeck LLC | 13 | $206 |
| Axsome Therapeutics, Inc. | 10 | $175 |
Products named: UZEDY, AUSTEDO XR, REXULTI, ARISTADA, COBENFY, FANAPT, VRAYLAR, SPRAVATO.
Industry payments across MA — which companies pay providers there.
